Reaction profile

The FDA adverse-event record for pr-bronchi, lesion(s)

13 FDA reports name pr-bronchi, lesion(s), a lower-volume reaction in the CVM extract (VeDDRA 99596). Plate stamps and neighbourhood peers follow.

#2367 of 2,481
by report volume (all reactions)
13
reports citing this reaction
100.0%
death-coded share
Cat
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-BRONCHI, LESION(S) has 13 reports now versus 13 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-BRONCHI, LESION(S) changes

FDA AER · VeDDRA plate

Code 99596 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 13 reports
  • DEATH-HOT 100.0%
  • BOTTOM-DECILE #2367/2481
  • PHOTO-FINISH Abnormal digital pulse
  • SPECIES-CAT Cat · 6
  • DRUG-LEAD Spinosad · 2
  • DESK-WIDE 10 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal digital pulse (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-BRONCHI, LESION

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal digital pulse · near13Acute haemorrhagic pa… · near13Acute jaundice · near13Application site mass… · near13PR-BRONCHI, LESION(S) · this…13Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around PR-BRONCHI, LESION(S)

PR-BRONCHI, LESION(S): high death-coded share in the FDA AER plate

Signature read: PR-BRONCHI, LESION(S)'s 100.0% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 13 named reports in the openFDA extract. Death-coded share is upper-third: 13 of 13 reports (100.0% of named reports). Nearest volume peer: Abnormal digital pulse (±0 reports). Lead species Cat (6). Lead co-reported drug Spinosad (2).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 6
Cattle 4
Dog 3

Breeds Most Affected

Domestic (unspecified) 3
Domestic Shorthair 2
Crossbred Canine/dog 1
Bichon Frise 1
Crossbred Bovine/Cattle 1
Mixed (Cattle) 1
Cattle (unknown) 1
Beefmaster 1
Retriever - Labrador 1
Domestic Mediumhair 1

Associated Drugs

Spinosad 2
Moxidectin 2
Imidacloprid, Moxidectin 1
Tiletamine, Zolazepam 1
Milbemycin 1
Meloxicam 1
Isoflupredone 1
Zeranol 1
Atipamezole Hydrochloride 1
Dexmedetomidine Hydrochloride 1
Butorphanol Tartrate 1
Atropine 1
Epinephrine 1
Eprinomectin 5% Injection 1
Merial La Polypropylene Syringe 1
Rabacfosadine 1
Cbd Oil 1
Trazodone 1
Mirtazapine 1
Maropitant 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-BRONCHI, LESION(S) (#2367 of 2,481 by report volume); death-coded 100.0%. PlainBreed reaction plate · death-coded share stamp 100.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →